Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • frymor
    Senior Member
    • May 2010
    • 151

    bowtie -m option

    Hi everybody,

    maybe I misunderstood it completely, but what is the option -m good for?
    If I am looking for differentially regulated genes in my data set and i set a high m-value (lets say 5), I know there are for some reads up to five different possible locations which they can be matched.

    @what exactly does it mean for my data?

    Do I have my read at different positions on the reference genome?
    This way my data for differentially expressed genes will be biased.
    Do I have these reads at five locations or there is just one, best location where it mapped to.

    I have pair-end data set, so I can't use the best and strata combination.
    @What I don't exactly understand is the definition of uniqueness in the bowtie -m option?

    If I use the option -m 1 I will loose a large part of my data, so I don't want to do it, but I would like to see, that the reads are mapped are as specific as possible.
    the command I use to run bowtie is as such:
    bowtie -a -m 5 -n 2 -l 22 -q --un total_trimmed.unmapped -t -p 2 -5 11 --chunkmbs 256 --max total_5trimmed.maxHits -S d_melanogaster_fb5_32 -1 s2_1_sequence.fq -2 s2_2_sequence.fq total_5trimmed.sam
  • waseem
    Member
    • May 2011
    • 11

    #2
    m 1, as I understood will give you the reads that map to only 1 location. (unique reads). My approach is, these reads are counted as true counts (given more weights). The reads mapping at multiple locations might be separated into reads mapping at alternatively spliced variants (different variants of same gene models) and the reads mapping to different genes (multi reads). I am working on separating these reads and counting them with different weights.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    16 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    18 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    24 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    37 views
    0 reactions
    Last Post SEQadmin2  
    Working...